IBM (United States) · US
Meistzitierte Publikationen im Bereich Gesundheit & MedTech
Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study
2024 · 1 Zit. · JMIR Public Health and Surveillance